{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:50Z","timestamp":1707525170903},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"DOI":"10.7759\/cureus.40658","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T23:24:05Z","timestamp":1687217045000},"source":"Crossref","is-referenced-by-count":0,"title":["Need for Early Recognition of Amyloidosis in Cases of Unexplained Heart Failure: A Case Report"],"prefix":"10.7759","author":[{"given":"Sneha","family":"Kalluri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7175\/rhc.v4i4.662","article-title":"Overview of systemic and localized amyloidosis","volume":"4","author":"Girnius S","year":"2013","unstructured":"Girnius S. Overview of systemic and localized amyloidosis. Rev Health Care. 2013, 4:231-47. 10.7175\/rhc.v4i4.662","journal-title":"Rev Health Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26289","article-title":"Should we measure clonal circulating plasma cells in light chain amyloidosis?","volume":"9","author":"Sidana S","year":"2018","unstructured":"Sidana S, Kumar SK, Gonsalves WI. Should we measure clonal circulating plasma cells in light chain amyloidosis?. Oncotarget. 2018, 9:35607-8. 10.18632\/oncotarget.26289","journal-title":"Oncotarget"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-017-0273-5","article-title":"Light chain (AL) amyloidosis: the journey to diagnosis","volume":"11","author":"McCausland KL","year":"2018","unstructured":"McCausland KL, White MK, Guthrie SD, Quock T, Finkel M, Lousada I, Bayliss MS. Light chain (AL) amyloidosis: the journey to diagnosis. Patient. 2018, 11:207-16. 10.1007\/s40271-017-0273-5","journal-title":"Patient"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0159","article-title":"Amyloidosis-the diagnosis and treatment of an underdiagnosed disease","volume":"117","author":"Ihne S","year":"2020","unstructured":"Ihne S, Morbach C, Sommer C, Geier A, Knop S, St\u00f6rk S. Amyloidosis-the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int. 2020, 117:159-66. 10.3238\/arztebl.2020.0159","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01490-2","article-title":"When and how do patients with cardiac amyloidosis die?","volume":"109","author":"Escher F","year":"2020","unstructured":"Escher F, Senoner M, Doerler J, et al.. When and how do patients with cardiac amyloidosis die?. Clin Res Cardiol. 2020, 109:78-88. 10.1007\/s00392-019-01490-2","journal-title":"Clin Res Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.08.009","article-title":"AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: CardioOncology state-of-the-art review","volume":"4","author":"Wechalekar AD","year":"2022","unstructured":"Wechalekar AD, Fontana M, Quarta CC, Liedtke M. AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2022, 4:427-41. 10.1016\/j.jaccao.2022.08.009","journal-title":"JACC CardioOncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2009.11928533","article-title":"Light chain amyloidosis: a case presentation and review","volume":"22","author":"Melmed GM","year":"2009","unstructured":"Melmed GM. Light chain amyloidosis: a case presentation and review. Proc (Bayl Univ Med Cent). 2009, 22:280-3. 10.1080\/08998280.2009.11928533","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02740806","article-title":"Light-chain (AL) amyloidosis: diagnosis and treatment","volume":"1","author":"Sanchorawala V","year":"2006","unstructured":"Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006, 1:1331-41. 10.2215\/CJN.02740806","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2019.07.010","article-title":"Approach to a patient with cardiac amyloidosis","volume":"16","author":"Strouse C","year":"2019","unstructured":"Strouse C, Briasoulis A, Fonseca R, Jethava Y. Approach to a patient with cardiac amyloidosis. J Geriatr Cardiol. 2019, 16:567-74. 10.11909\/j.issn.1671-5411.2019.07.010","journal-title":"J Geriatr Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018, 18:s30-5. 10.7861\/clinmedicine.18-2-s30","journal-title":"Clin Med (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2017.10.003","article-title":"Recent advances in diagnosis and treatment of cardiac amyloidosis","volume":"71","author":"Izumiya Y","year":"2018","unstructured":"Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. J Cardiol. 2018, 71:135-43. 10.1016\/j.jjcc.2017.10.003","journal-title":"J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan M","year":"2017","unstructured":"Grogan M, Dispenzieri A, Gertz MA. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart. 2017, 103:1065-72. 10.1136\/heartjnl-2016-310704","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-021-00236-z","article-title":"Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications","volume":"10","author":"Xu L","year":"2021","unstructured":"Xu L, Su Y. Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications. Exp Hematol Oncol. 2021, 10:43. 10.1186\/s40164-021-00236-z","journal-title":"Exp Hematol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/479314","article-title":"Catastrophic cardiac amyloidosis","volume":"2011","author":"Panduranga P","year":"2010","unstructured":"Panduranga P, Mukhaini M. Catastrophic cardiac amyloidosis. Cardiol Res Pract. 2010, 2011:479314. 10.4061\/2011\/479314","journal-title":"Cardiol Res Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1999.tb01390.x","article-title":"New insights into the role of serum amyloid P component,  a novel lipopolysaccharide-binding protein","volume":"26","author":"de Haas CJC","year":"1999","unstructured":"de Haas CJC. New insights into the role of serum amyloid P component,  a novel lipopolysaccharide-binding protein. FEMS Immunol Med Microbiol. 1999, 26:197-202. 10.1111\/j.1574-695X.1999.tb01390.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20389","article-title":"Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review","volume":"32","author":"Dhoble A","year":"2009","unstructured":"Dhoble A, Khasnis A, Olomu A, Thakur R. Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review. Clin Cardiol. 2009, 32:E63-5. 10.1002\/clc.20389","journal-title":"Clin Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13681","article-title":"Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement","volume":"107","author":"Oubari S","year":"2021","unstructured":"Oubari S, Naser E, Papathanasiou M, et al.. Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement. Eur J Haematol. 2021, 107:449-57. 10.1111\/ejh.13681","journal-title":"Eur J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-8-3-3","article-title":"The amyloidoses: clinical features, diagnosis and treatment","volume":"8","author":"Baker KR","year":"2012","unstructured":"Baker KR, Rice L. The amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012, 8:3-7. 10.14797\/mdcj-8-3-3","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set Oversight Committee","volume":"81","author":"Kittleson MM","year":"2023","unstructured":"Kittleson MM, Ruberg FL, Ambardekar AV, et al.. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set Oversight Committee. J Am Coll Cardiol. 2023, 81:1076-126. 10.1016\/j.jacc.2022.11.022","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155239-need-for-early-recognition-of-amyloidosis-in-cases-of-unexplained-heart-failure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:33Z","timestamp":1707509073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155239-need-for-early-recognition-of-amyloidosis-in-cases-of-unexplained-heart-failure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.40658","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}